Bone-Protective Agents Beneficial in Patients Receiving Radium-223 for Metastatic Prostate Cancer
Researchers emphasized the importance of bone-protective agents in patients treated for metastatic castration-resistant prostate cancer.
Read More
Dissemination (Spotlight)
Predicting Survival in Newly Diagnosed Metastatic Prostate Cancer: The Value of PSMA PET Imaging & AI
Researchers found correlations between PSMA PET total tumor burden and survival in patients with high-volume metastatic hormone-sensitive prostate cancer.
Read More
Examining the Impact of Aspirin on Key COPD Results
The following is a summary of “Effectiveness of Aspirin on Major COPD Outcomes: A Prevalent...
Read More
Insights of Smartwatch and Smartphone Self-Management Tools in COPD Care
The following is a summary of “Impressions and Perceptions of a Smartphone and Smartwatch...
Read More
Exploring Functional Performance and Respiratory Oscillometry Across COPD Phenotypes
The following is a summary of “Respiratory Oscillometry and Functional Performance in Different...
Read More
VMAT2 Inhibitors Efficacious & Safe for Treating Tardive Dyskinesia
Several clinical trials have tested the efficacy and safety of valbenazine and deutetrabenazine in patients with TD.
Read More
Disassociation of High BEC From Airway Microbiota Profile in Stable COPD
The following is a summary of “High Blood Eosinophil Count at Stable State is Not Associated with...
Read More
Validating an Algorithm for Automated Quantification of QT-Intervals in COPD Patients
The following is a summary of “Automated Quantification of QT-Intervals by an Algorithm: A...
Read More
Examining the Role of Nutrition in Crohn’s Disease and Ulcerative Colitis
Emerging evidence underscores the significant impact of diet on IBD development and treatment.
Read More
Exploring the Benefits of Deep Brain Stimulation in Tardive Dyskinesia
Deep brain stimulation offers advantages such as adjustability, reversibility, and the potential for rapid and long-term improvement in tardive dyskinesia.
Read More
The Potential of Microbiota Manipulation in IBD Treatment
Targeted microbiota manipulation using probiotics, prebiotics, synbiotics, and fecal microbiota transplantation holds potential for IBD treatment.
Read More
Tools for Measuring Tardive Dyskinesia: Clinical Implementation & Recent Advancements
Annual training and reliable new tools can help physicians improve tardive dyskinesia screening and symptom measurement.
Read More
Addressing Insomnia & Mental Health in Crohn’s Disease
Patients with inflammatory bowel diseases often experience insomnia and various mental health conditions that healthcare providers should monitor.
Read More
Western World Reports Improved Hospitalization Stability for Crohn’s & Colitis
Advances in the management of IBD may support a shift from hospital-based care to community-based care.
Read More
Tardive Dyskinesia: A Comprehensive Look at the Condition and Its Management
There are approximately 600,000 people in the US who are living with TD—65% of them have not been diagnosed.
Read More
Switching from IV to Subcutaneous Vedolizumab Deemed Safe & Effective
Study results indicate that switching from intravenous to subcutaneous vedolizumab in patients with IBD appears to be safe and effective.
Read More
The Tardive Dyskinesia Impact Scale Provides a Holistic Evaluation for Physicians
The Tardive Dyskinesia Impact Scale complements the Abnormal Involuntary Movement Scale by combining clinician-rated and patient-reported perspectives.
Read More
Extrapyramidal Rating Scale Effectively Measures Tardive Dyskinesia Symptoms
The Extrapyramidal Symptom Rating Scale and an abbreviated version of the scale were both validated for measuring the impact of tardive dyskinesia.
Read More
82% of Caregivers Say Tardive Dyskinesia Severely Impacts Patients
Tardive dyskinesia impacts both the patients living with the movement disorder and those who care for them.
Read More
Patients’ Views on Impact of Tardive Dyskinesia Challenge Clinician Assessments
Patients consistently felt possible TD impacted their lives, regardless of rating method, suggesting clinician assessments might miss its actual burden.
Read More